Lataa...
Emerging treatment strategies for glioblastoma multiforme
Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. GBM has a paltry median survival of 12.6 months attributed to the unique treatment limitations such as the high average age of onset, tumor location, and poor current understandings of the tumor...
Tallennettuna:
| Julkaisussa: | EMBO Mol Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BlackWell Publishing Ltd
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4237465/ https://ncbi.nlm.nih.gov/pubmed/25312641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201302627 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|